Argent Biopharma Ltd (RGT) — Cash Flow Quality Index
Argent Biopharma Ltd (RGT) has a Cash Flow Quality Index of -4.11x as of September 2018. Operating cash flow of AU$-1.34 Million is below net income of AU$326.24K, suggesting accrual-heavy earnings not yet converted to cash. Explore Argent Biopharma Ltd (RGT) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Argent Biopharma Ltd Cash Flow Quality Index (2006–2011)
Historical Cash Flow Quality Index for Argent Biopharma Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check RGT cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Argent Biopharma Ltd (2006–2011)
Year-by-year earnings quality comparison for Argent Biopharma Ltd. For live market cap and the full company financial profile, see RGT market cap.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2011 | -0.18x | AU$-338.82K | AU$1.94 Million | ▼ -180.3% |
| 2006 | 0.22x | AU$41.00K | AU$188.00K | — |